Difference between revisions of "Main Page"
m |
|||
| Line 4: | Line 4: | ||
#Creating a database of [[chemotherapy]] agents. | #Creating a database of [[chemotherapy]] agents. | ||
| − | #Creating an index of diseases. | + | #Creating an index of [[diseases]]. |
#Creating a list of active [[BIDMC clinical trials]] that can be used by current providers. | #Creating a list of active [[BIDMC clinical trials]] that can be used by current providers. | ||
| − | #Creating a [[List_of_chemotherapy_regimens|list of chemotherapeutic regimens]], references to primary literature (PubMed and directly to the abstract/full article) | + | #Creating a [[List_of_chemotherapy_regimens|list of chemotherapeutic regimens]], common order sets, including supportive medications, and references to primary literature (PubMed and directly to the abstract/full article). |
#Creating checklists that can be used for patients starting therapy with particular regimens. Areas of focus will include: informed consent/discussion of side effects, supportive medications, dose/schedule adjustments, and the chemotherapy orders themselves. | #Creating checklists that can be used for patients starting therapy with particular regimens. Areas of focus will include: informed consent/discussion of side effects, supportive medications, dose/schedule adjustments, and the chemotherapy orders themselves. | ||
Revision as of 05:18, 14 November 2011
HemOnc.org
This is a project in development as of 11/11/11 that is intended to be a reference for hematology/oncology professionals. Priorities of this project will initially consist of:
- Creating a database of chemotherapy agents.
- Creating an index of diseases.
- Creating a list of active BIDMC clinical trials that can be used by current providers.
- Creating a list of chemotherapeutic regimens, common order sets, including supportive medications, and references to primary literature (PubMed and directly to the abstract/full article).
- Creating checklists that can be used for patients starting therapy with particular regimens. Areas of focus will include: informed consent/discussion of side effects, supportive medications, dose/schedule adjustments, and the chemotherapy orders themselves.
The field of hematology/oncology is ever-changing, and I believe that the collaborative efforts of a group of dedicated contributors can result in a far more useful resource than one maintained by a sole person. The ever-changing nature of the practice demands a more dynamic medium than existing resources can provide and one which can be updated in real-time from virtually any computer with internet access. Although there is no formal protocol in place for peer review, the informal peer review and fact-checking that will take place by means of use of this site will be invaluable. I believe that the familiar format of a Wiki, made popular by sites such as Wikipedia, will significantly help ease-of-use and navigation.
If you would like to contribute, please create an account in the upper right corner, and contact me at [email protected] so that your account can be set up with the necessary rights. Due to the sensitive nature of the information contained within this site, unverified users will not be allowed to edit articles.
Old info about Getting started
Consult the User's Guide for information on using the wiki software.